Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · IEX Real-Time Price · USD
5.33
+0.01 (0.19%)
At close: Jul 19, 2024, 4:00 PM
5.31
-0.02 (-0.38%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Inozyme Pharma Market Cap
Inozyme Pharma has a market cap or net worth of $329.69 million as of July 22, 2024. Its market cap has increased by 43.72% in one year.
Market Cap
329.69M
Enterprise Value
209.86M
1-Year Change
43.72%
Ranking
Category
Stock Price
$5.33
Market Cap Chart
Since July 24, 2020, Inozyme Pharma's market cap has decreased from $382.60M to $329.69M, a decrease of -13.83%. That is a compound annual growth rate of -3.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 329.70M | 25.31% |
| Dec 29, 2023 | 263.10M | 520.52% |
| Dec 30, 2022 | 42.40M | -73.73% |
| Dec 31, 2021 | 161.40M | -66.54% |
| Dec 31, 2020 | 482.40M | 26.08% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cabaletta Bio | 342.28M |
| ModivCare | 335.24M |
| Nevro | 334.23M |
| Kamada | 332.20M |
| ADC Therapeutics | 331.02M |
| Nautilus Biotechnology | 326.94M |
| XOMA Corporation | 326.58M |
| Foghorn Therapeutics | 326.44M |